COMPOSITIONS AND METHODS FOR CRYSTALLIZING ANTIBODIES
The present invention relates to a batch crystallization method for crystallizing anti-human TNFalpha (hTNFalpha) antibody and antibody fragments which allows the production of said antibody on an industrial scale; a method of controlling the size of antibody crystals, for example, crystals of anti-...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French |
Published |
12.02.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a batch crystallization method for crystallizing anti-human TNFalpha (hTNFalpha) antibody and antibody fragments which allows the production of said antibody on an industrial scale; a method of controlling the size of antibody crystals, for example, crystals of anti-hTNFalpha antibody fragments, compositions containing said crystals as well as methods of use of said crystals and compositions.
La présente invention se rapporte à un procédé de cristallisation discontinu permettant de cristalliser l'anticorps et les fragments d'anticorps antihumain TNFalpha (hTNFalpha). Ce procédé permet la production dudit anticorps à l'échelle industrielle. L'invention concerne également un procédé de contrôle de la taille de cristaux d'anticorps, par exemple, de cristaux de fragments d'anticorps anti-hTNFalpha, les compositions contenant lesdits cristaux ainsi que les procédés d'utilisation des cristaux et des compositions. |
---|---|
Bibliography: | Application Number: WO2008US09549 |